Textbook Monthly Accumulation After a Decade-Long Decline

Textbook Monthly Accumulation After a Decade-Long Decline

Yesterday’s video lesson on accumulation and distribution, drawn from the live stream earlier in the week, pulled in more than 1,400 views in 24 hours. That tells me something important. Traders want to see the same principles in a live stock, not just in theory. This week we stay on that subject and turn to Perrigo, ticker PRGO, in the consumer medical and self-care sector. This is a classic example of long-term accumulation by professional money.

On the monthly chart, the story is written in volume and spread. Over the last twelve months, we have seen a dramatic ramp in volume, extreme monthly volumes, and narrow-spread candles. That combination doesn’t happen by accident. It is how market makers and informed insiders absorb stock quietly while the crowd is still looking the other way. Wyckoff’s second law, Cause and Effect, then tells us what should follow: a large cause on the higher timeframe produces a large effect. The daily chart has now given the first signal of that effect, with an initial move out of congestion. This is not a tip. It is a worked example of Volume Price Analysis as we teach it in the programme.

Company background

Perrigo is one of the original names in over-the-counter self-care. The business dates back to 1887. Today, it is an Ireland-domiciled company listed in New York, supplying store-brand OTC products to major US retailers and branded self-care products in Europe. Think cough and cold, pain relief, women’s health, skincare, nutrition and infant formula. In North America, it is a major private-label supplier to Walmart, Amazon, Costco, and pharmacy chains. In Europe, the portfolio includes names such as Compeed, Solpadeine and ellaOne.That sounds dull. For VPA students it is useful. Dull cash-generative consumer health names often spend years being distributed, then years being accumulated, because the float is large, the institutions are patient, and the public only wakes up when the trend is already obvious. The price history makes the point. Unadjusted, PRGO traded above $200 in April 2015. The widely quoted closing high around that period was about $150, with some tick data prints above $215. From that peak, the stock has been in a long, grinding decline. By March 2026, it had tagged a 52-week low near $9.23. That is an 80–90% collapse from the old highs, depending on which print you use. A fall of that size is exactly the environment in which professional money can accumulate without chasing price.

The current fundamental picture

The fundamental tape is mixed, which is typical of a stock still in the later stages of a long base. Trailing twelve-month revenue is still around $4.1–4.3 billion. Market capitalisation is only about $2 billion. On a simple sales multiple, that is cheap. Book value is close to the share price. The company still pays a quarterly dividend of $0.29, or $1.16 a year. At recent prices around the mid-teens, that is a yield near 8%. A high yield after a collapse often means the market does not trust the payout. It can also mean the stock has been sold to a level where income buyers and strategic holders start to appear.GAAP earnings look ugly. Trailing EPS is deeply negative, largely because of impairments, restructuring and portfolio clean-up rather than a business that has simply vanished. Management has been running a “Three-S” plan: streamline, strengthen and scale.

They sold the dermacosmetics business, raising about €306 million to reduce debt. Infant formula and oral care have been under strategic review. The company has recorded a large non-cash goodwill impairment. Debt is still material, with total debt recently in the $3.3–3.6 billion range and leverage still elevated. The operating story underneath the write-downs is more useful. Core adjusted EPS guidance for 2026 has been held in a $2.25 to $2.55 range. Q2 2026 adjusted EPS beat consensus even though sales were still soft. After that print, the stock jumped sharply, including a very large up month in August.

Management points to a stronger second half: cost savings from the operational enhancement programme, better comparisons, innovation, and gains in store-brand share. So the fundamental snapshot is this: a scaled self-care franchise, still carrying too much debt and too much history, now being simplified, still generating cash, still paying a dividend, and valued as if the market has given up on a recovery. That is often when the monthly chart starts to show absorption.

VPA first: what the monthly chart is saying

Volume Price Analysis does not begin with a moving average cross. It begins with effort versus result. On the monthly timeframe, effort is volume. Result is the spread of the candle and where price closes inside that spread. When you see extreme volume and a narrow spread, the market is telling you that a huge amount of stock changed hands without price being allowed to fall far. Somebody was on the other side of that buying and absorbing. In a stock that has already fallen from the $200 area to single digits and low teens, that “somebody” is not a panicked retail seller. It is professional demand. Quiet accumulation and stocking of the market makers warehouse.

Over the last twelve months, PRGO has shown exactly that pattern. Volume expanded sharply into the late-2025 break and the spring-2026 low. Several months printed heavy turnover while the monthly range stayed controlled. That is accumulation, not distribution. In distribution, high volume usually appears near highs, and the spreads widen downward as supply overwhelms demand. Here the opposite has been happening: large volume near the lows, contained spreads, and then a refusal to make a new collapse. This is also why we keep students on the slower timeframes. A daily spike can be noise. A weekly can be a campaign. A monthly with rising volume and narrowing ranges after a multi-year decline is a campaign measured in years, not sessions.

Wyckoff’s second law: Cause and Effect

Richard Wyckoff’s second law is simple and brutal. The size of the cause determines the size of the effect. The cause is the time and volume spent in the accumulation range. The longer the base and the more stock absorbed, the larger the subsequent trend can be. PRGO did not spend three weeks in a tight box. It spent years coming down from the old highs and then a concentrated twelve-month period of heavy volume near the lows. That is a large cause. The effect should therefore not be a two-day bounce. If the reading is correct, the effect is an extended mark-up. That mark-up does not have to start with a vertical explosion. It often starts exactly as we have just seen on the daily chart: an initial push out of congestion after the professional inventory has been built. Cause and Effect also explains why so many traders get shaken out. They see a beaten-up healthcare name, a high yield, impairments and debt, and they assume the only possible next chapter is more decline. The professionals use that narrative to buy. The public uses that narrative to sell. Volume on the monthly chart records the transfer.

The daily chart: first evidence of the effect

The monthly tells us the campaign. The daily tells us when the campaign starts to pay. This week the daily chart signalled an initial move out of congestion. That is the first public evidence that the stock is no longer only being absorbed. Price is beginning to leave the range. In VPA terms, we now watch the quality of that departure:

• Does volume support the up candles?
• Do the down candles on the pullback come in on falling volume and narrow spreads?
• Does price hold above the old congestion rather than slip straight back in?

If the answer is yes, the daily is confirming the monthly. If the answer is no, the stock is still in the testing phase of the range. Either way, the monthly cause is already on the chart. The daily is simply the first attempt to express it. Remember the August 2026 surge after the Q2 numbers. That kind of event often looks like “news” to the fundamental crowd. To a VPA trader, itis often the moment when accumulated stock is allowed to revalue because the inventory is already in strong hands.

How this is taught in the programme

In the programme, we do not start with a target price. We start with a process.

1. First, identify the major trend on the monthly and weekly. PRGO’s major trend from 2015 was down. That phase is the distribution and markdown.
2. Second, look for a change in volume character at the lows. Extreme volume plus narrow spreads is the footprint of absorption.
3. Third, apply Law 2. Ask how large the cause is. A twelve-month volume expansion after a collapse from over $200 is not a small cause.
4. Fourth, drop to the daily only after the higher-timeframe story is clear. Use the daily to time the first departure from congestion, not to invent a thesis that the monthly does not support.
5. Fifth, manage risk as if the effect can take months to mature. Accumulation campaigns fail when students treat the first up week as the whole trade.

I am using PRGO this week because it is clean. The history is extreme. The sector is understandable. The volume story on the slow chart is visible. The daily has now given students a live “effect” candle to study, rather than a hindsight example from five years ago.

What this is not

It is not a promise that PRGO returns to $200. Cause and Effect describes the potential size of a move relative to the work done in the range. It does not abolish debt, competition, infant-formula risk or a weak consumer. A stock can be accumulated and still spend a long time being absorbed – remember the oil tanker!. A breakout can fail and return to the range for another test. That is why we read volume on the way up as carefully as we read it on the way down. If mark-up begins and volume dries up, the effect is weak. If pullbacks are sold on rising volume and wide spreads, supply has returned. The same method that identified the accumulation will identify a failed campaign.

Closing the week

PRGO reminds us why the last video travelled. Accumulation is not a slogan. It is a specific relationship between volume, spread and location on the chart. Here the location is a multi-year low after a fall from well over $200. The volume is elevated. The monthly spreads have been contained. The professionals have had time to do the work. The daily has started to break out of congestion. That is Law 2 in plain language. A large cause has been built. The effect, if it continues to confirm, should be a trend measured in months and years, not in hours. Study the monthly first. Then judge the daily departure on its own volume. That is the lesson for the week, and it is exactly how we train the method in the programme.

By Anna Coulling – creator of volume price analysis

By Anna Coulling – creator of volume price analysis